Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

ClinicalTrials.gov ID: NCT05592275

Public ClinicalTrials.gov record NCT05592275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Study identification

NCT ID
NCT05592275
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
332 participants

Conditions and interventions

Interventions

  • LY3540378 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2, 2023
Primary completion
Jan 21, 2025
Completion
Jan 21, 2025
Last update posted
Feb 4, 2026

2023 – 2025

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
21
Facility City State ZIP Site status
Pima Heart Tucson Arizona 85719
Valley Clinical Trials, Inc. Covina California 91723
Valley Clinical Trials, Inc. Northridge California 91325
University of California Irvine Medical Center Orange California 92868
Pasadena Clinical Research Pasadena California 91105
Velocity Clinical Research, Coastal Heart Medical Group Santa Ana California 92704
Excel Medical Clinical Trials Boca Raton Florida 33434
Infinite Clinical Research Miami Florida 33133
South Florida Research Solutions - North Flamingo Road Pembroke Pines Florida 33028
University Medical Center New Orleans New Orleans Louisiana 70112
Boston Medical Center Boston Massachusetts 02118
Henry Ford Hospital Detroit Michigan 48202
Mayo Clinic in Rochester, Minnesota Rochester Minnesota 55905
University of North Carolina Medical Center Chapel Hill North Carolina 27514
Abington Memorial Hospital Abington Pennsylvania 19001
PharmaTex Research Amarillo Texas 79109
Baylor Scott & White Health-Advanced Heart and Lung Disease Dallas Texas 75246
UT Southwestern Medical Center Dallas Texas 75390
University of Texas Medical Branch Galveston Texas 77555-0553
West Houston Area Clinical Trial Consultants Houston Texas 77094
Texas Institute of Cardiology, PA McKinney Texas 75071
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 115 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05592275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05592275 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →